-
-
-
-
-
-
-
Theravance Biopharma Responds to COVID-19 Pandemic by Advancing TD-0903 to Treat Hospitalized Patients with Acute Lung Injury
-
-
-
-
-
-
-
Theravance Biopharma, Inc. Reports Second Quarter 2015 Financial Results and Provides Business Update
-
-
-
73,851 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


